Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran

被引：0
|
作者：
Job Harenberg
Ingrid Jörg
Christel Weiss
机构：
[1] University Hospital Mannheim,IV. Department of Medicine
[2] University Hospital Mannheim,Institute for Biometry and Medical Statistics
来源：
European Journal of Clinical Pharmacology | 2006年 / 62卷
关键词：
Follow-up; Low-molecular weight heparin; Venous thromboembolism; Warfarin; Ximelagatran;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：173 / 177
页数：4
相关论文
共 50 条
  • [1] Incidence of recurrent venous thromboembolism of patients after termination of treatment with ximelagatran
    Harenberg, J
    Joerg, I
    Weiss, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 173 - 177
  • [2] The role of ximelagatran in the treatment of venous thromboembolism
    Schulman, S
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 : 18 - 24
  • [3] Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran
    Harenberg, J
    Ingrid, J
    Tivadar, F
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (11): : 1003 - 1005
  • [4] Ximelagatran for secondary prevention of venous thromboembolism
    Böger, C
    Schroll, S
    Holmer, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06): : 618 - 618
  • [5] Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism
    Schulman, S
    Lindmarker, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26): : 1953 - 1958
  • [6] Incidence and Risk Factors of Recurrent Venous Thromboembolism after Pulmonary Embolism
    Hwang, Hun-Gyu
    Choi, Won-Il
    Lee, Bora
    Lee, Choong Won
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2019, 82 (04) : 341 - 347
  • [7] Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment
    Satoh, Toyomi
    Matsumoto, Koji
    Tanaka, Yumiko O.
    Akiyama, Azusa
    Nakao, Sari
    Sakurai, Manabu
    Ochi, Hiroyuki
    Onuki, Mamiko
    Minaguchi, Takeo
    Sakurai, Hideyuki
    Yoshikawa, Hiroyuki
    THROMBOSIS RESEARCH, 2013, 131 (04) : E127 - E132
  • [8] The incidence of recurrent venous thromboembolism in a defined population
    Mos, I. C. M.
    Tan, M.
    Klinkenberg, M.
    van der Meer, F. J. M.
    Huisman, M., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 855 - 855
  • [9] Incidence of venous thromboembolism after standard treatment in patients with epithelial ovarian cancer in Korea
    Shin, Wonkyo
    Lee, Sanghee
    Lim, Myong Cheol
    Jung, Jipmin
    Kim, Hak Jin
    Cho, Hyunsoon
    CANCER MEDICINE, 2021, 10 (06): : 2045 - 2053
  • [10] Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
    Wåhlander, K
    Eriksson, H
    Lundström, T
    Clason, SB
    Wall, U
    Nyström, P
    Wessman, P
    Schulman, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (01) : 68 - 77
12345